The DOI matches its Crossref record; 68 of the 70 references it cites were found in a registry or an index.
Smoking and schizophrenia: abnormal nicotinic receptor expression
Abstract
Biological and genetic evidence suggests a role for the neuronal nicotinic receptors in the neuropathophysiology of schizophrenia. Nicotine normalizes an auditory evoked potential deficit seen in subjects who suffer from the disease. Nicotinic receptors with both high and low affinity for nicotine are decreased in postmortem brain of schizophrenics compared to control subjects. The chromosomal locus of the human alpha-7 gene (15q14) is linked to the gating deficit with a lod of 5.3, and antagonists of the alpha-7 receptor (alpha-bungarotoxin and methyllycaconitine) induce a loss of gating in rodents. We have cloned the human alpha-7 gene and found it to be partially duplicated proximal to the full-length gene. The duplication is expressed in both the brain and in peripheral blood cells of normal subjects, but is missing in some schizophrenic subjects. The results of these studies suggest the presence of abnormal expression and function of the neuronal nicotinic receptor gene family in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic and functional studies have implicated α7 nAChRs in prepulse inhibition, a physiological marker associated with schizophrenia (Leonard et al. 2000;Freedman et al. 2003).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Leonard et al. 2000
Citations
Cites
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Self-citationPrevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citationSchizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
Self-citation
Research works printed but not linked: 7
- Benhammou, 1999, Peripheral blood lymphocytes, neutrophils and immortalized lymphoblasts have defined patterns of nicotinic receptor subunit expression, J. Neurochem.
- Goff, 1980, Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man, Prog. Clin. Neurophysiol., 7, 126
- Lee, 1999, The effect of nicotine and haloperidol co-treatment on high and low affinity nicotinic and dopamine receptor levels in the rat brain, Neuropsychopharmacology
- Leonard, 1998, Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH genetics initiative, Am. J. Med. Genet., 81, 308, 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P · DOI
- Logel, 1997, Expression of high and low affinity neuronal nicotinic receptors in tissues of neural crest origin, Soc. Neurosci. Abstr., 23, 382
- Riley, 1997, Further suggestive evidence for involvement of the α-7 nicotinic cholinergic receptor gene on chromosome 15q13–q14 in schizophrenia, Am. J. Hum. Genet., 61, 232
- Rollins, 1993, Reduction in auditory gating following intracerebroventricular application of α-bungarotoxin binding site ligands and α-7 antisense oligonucleotides, Soc. Neurosci. Abstr., 19, 837
Cited by
Sorted by citations
Items 101–180 of 180
O’Donnell, W. J., Kradin, R. L., Evins, A. E., & Wittram, C. (2004) · New England Journal of Medicine · doi:10.1056/nejmcpc049030 · Cited by 16
Quisenaerts, C., Morrens, M., Hulstijn, W., de Boer, P., Timmers, M., Sabbe, B., & de Bruijn, E. R. A. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00197 · Cited by 15
Impact of Smoking Cessation on Psychiatric Inpatients Treated with Clozapine or Olanzapine
Cole, M. L., Trigoboff, E., Demler, T. L., & Opler, L. A. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000369968.80155.3f · Cited by 15
Exogenous nicotine normalises sensory gating in schizophrenia; therapeutic implications
Conway, J. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.02.017 · Cited by 15
Huang, L., Sherwood, J. L., Sun, Y., Lodge, D., & Wang, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00529.x · Cited by 15
Beinat, C., Reekie, T. A., Banister, S. D., O’Brien-Brown, J., Xie, T., Olson, T. T., Xiao, Y., Harvey, A. J., O'Connor, S. M., Coles, C. J., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.025 · Cited by 14
Kim, D. H., & Suh, Y. S. (2009) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2009.30.7.494 · Cited by 14
Nicotinic acetylcholine receptor ligands as potential therapeutics
Gündisch, D. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.9.1221 · Cited by 14
No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia
Bozikas, V. P., Niopas, I., Kafantari, A., Kanaze, F. I., Gabrieli, C., Melissidis, P., Gamvrula, K., Fokas, K., & Karavatos, A. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.002 · Cited by 14
Illicit drug use in heavy smokers with and without schizophrenia
Mackowick, K. M., Heishman, S. J., Wehring, H. J., Liu, F., McMahon, R. P., & Kelly, D. L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.04.012 · Cited by 13
Warum rauchen Schizophreniepatienten?
Cattapan-Ludewig, K., Ludewig, S., Sirot, E. J., Etzensberger, M., & Hasler, F. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1818-0 · Cited by 13
Stevens, K. E., Zheng, L., Floyd, K. L., & Stitzel, J. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.044 · Cited by 12
Self-citationRomano, E., Angelis, F. D., Ulbrich, L., Jaco, A. D., Fuso, A., & Laviola, G. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3388-y · Cited by 14
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities.
Manetti, D., Bellucci, C., Chiaramonte, N., Dei, S., Teodori, E., & Romanelli, M. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0169 · Cited by 15
Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain
Sharma, G., & Vijayaraghavan, S. (2008) · Substance Abuse Research and Treatment · doi:10.1177/117822180800100005 · Cited by 16
IUPHAR review: Moving beyond dopamine-based therapeutic strategies for schizophrenia
Moran, P. M., & Granger, K. T. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107727 · Cited by 13
Buck, J. M., Yu, L., Knopik, V. S., & Stitzel, J. A. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab138 · Cited by 11
Cholinergic mechanisms in schizophrenia: Current concepts
Raedler, T. J., & Tandon, R. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629410 · Cited by 11
Smoking and Schizophrenia: Treatment Approaches within Primary Care
Baker, A., Lubman, D. I., & Hides, L. M. (2010) · NOVA (University of Newcastle Australia) · Cited by 10
Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study
Aidelbaum, R., Labelle, A., Baddeley, A., & Knott, V. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117746903 · Cited by 10
Neurobiologic Basis of Nicotine Addiction and Psychostimulant Abuse: a Role for Neurotensin?
Fredrickson, P. A., Boules, M., Lin, S.-C., & Richelson, E. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.05.001 · Cited by 10
Jankowska, A., Satała, G., Partyka, A., Wesołowska, A., Bojarski, A. J., Pawłowski, M., & Chłoń‐Rzepa, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190710172002 · Cited by 10
Moss, S. J., Sharott, A., Goodhead, L. H., & Mitchell, S. N. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02948-5 · Cited by 10
Treating Tobacco Addiction in Schizophrenia: Where do we go From Here?
George, T. P., & Vessicchio, J. C. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00154.x · Cited by 9
Dean, B., Haroutunian, V. H., & Scarr, E. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.03.035 · Cited by 8
Zhong, C., Akmentin, W., Role, L. W., & Talmage, D. A. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.978837 · Cited by 9
Yu, J. (2010) · The Open Behavioral Science Journal · doi:10.2174/1874230001004010009 · Cited by 6
Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia
Montoya, I. D., & Vocci, F. J. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_09 · Cited by 7
Beinat, C., Banister, S. D., van Prehn, S., Doddareddy, M. R., Hibbs, D. E., Sako, M., Chebib, M., Tran, T. P., Al‐Muhtasib, N., Xiao, Y., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.052 · Cited by 7
Dean, B. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903270431 · Cited by 7
Prevalencia de consumo de cigarrillo en pacientes de la consulta psiquiátrica de Bucaramanga.
Campo, A., Díaz‐Martínez, L. A., Rueda, G. E., Rueda-Sánchez, M., & Farelo, D. (2004) · Colombia medica · doi:10.25100/cm.v35i.2.290 · Cited by 7
Potenza, M. N., Brodkin, E. S., Yang, B., Birnbaum, S. G., Nestler, E. J., & Gelernter, J. E. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301667 · Cited by 6
Tialam, G., Latha, S., Kumar, M., & Mallepalli, P. R. (2019) · Archives of Mental Health · doi:10.4103/amh.amh_40_18 · Cited by 6
Cholinergic regulation of decision making under risk of punishment
Kelly, M., Garner, M., Cooper, E. M., & Orsini, C. A. (2024) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2024.108018 · Cited by 5
Hammarlund, M. E., Darsalia, V., Mjörnstedt, F., Pattanaik, B., Mallard, C. E., Rocha‐Ferreira, E., Patrone, C., & Johansson, M. E. (2021) · Bioscience Reports · doi:10.1042/bsr20210736 · Cited by 5
Physical exercise activity in individuals with schizophrenia
Bassilios, B. (2005) · Minerva Access (University of Melbourne) · Cited by 4
Soshi, T., Noda, T., Ando, K., Nakazawa, K., Tsumura, H., & Okada, T. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00141 · Cited by 4
Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia
Bridgman, A. C., Barr, M. S., Goodman, M. S., Zomorrodi, R., Rajji, T. K., Foll, B. L., Chen, R. E., Daskalakis, Z. J., & George, T. P. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.031 · Cited by 4
Yu, J., Nagai, T., Ibi, D., Kitahara, Y., Nabeshima, T., & Yamada, K. (2010) · The Open Behavioral Science Journal · Cited by 4
Tabagisme et schizophrénie : impacts sur la maladie et son traitement
Légaré, N. (2008) · Drogues santé et société · doi:10.7202/016946ar · Cited by 3
Haustein, K.-O., & Groneberg, D. A. (2009) · Springer eBooks · doi:10.1007/978-3-540-87577-2_7 · Cited by 3
Brašić, J. R., & Kim, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00010-1 · Cited by 4
Oepen, G. (2002) · Informa Healthcare eBooks · doi:10.1201/9780203909027.ch4 · Cited by 3
Oepen, G. (2002) · CRC Press eBooks · doi:10.1201/b15278-5 · Cited by 3
Monterrubio, S., & Solowij, N. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.553 · Cited by 3
Smoking Effects in the Human Nervous System
Schuman‐Olivier, Z., Stoeckel, L. E., Weisz, E., & Evins, A. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00011-3 · Cited by 2
Santos, J. R., Tomaz, P. R. X., Issa, J. S., Gaya, P. V., Abe, T. O., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2020) · Genes · doi:10.3390/genes11070746 · Cited by 2
Stimulant Reversal of Cognitive Deficits
Wesensten, N. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.007 · Cited by 1
Animal Inhalation Models to Investigate Modulation of Inflammatory Bowel Diseases
Sasso, G. L., Schlage, W. K., Phillips, B. W., Peitsch, M. C., & Hoeng, J. (2018) · InTech eBooks · doi:10.5772/intechopen.69569 · Cited by 1
Smoking in Schizophrenia: Dependancy Assessment, Neurobiological Aspects and Management Difficulties
Bencharfa, Z., Amara, Y., Katir, I., Belbachir, S., & Ouanass, A. (2022) · SAS Journal of Medicine · doi:10.36347/sasjm.2022.v08i09.016 · Cited by 1
Noda, M. (2016) · Advances in Neuroimmune Biology · doi:10.3233/nib-160119 · Cited by 1
Einfluss des Rauchens auf weitere Organsysteme
Haustein, K.-O. (2008) · Springer eBooks · doi:10.1007/978-3-540-73309-6_8 · Cited by 1
Eales, K. L. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Mendes, C. C. C. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2009.tde-28082009-105421
Characterization of the Role of Nicotine and Delta 9-THC in Modulation of Neuroinflammation
Ehrhart, J. C. (2010) · Digital Commons - University of South Florida (University of South Florida)
Jayakar, S. S. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Novel pathways for stimulant development II: the hypocretin/orexin system
Pasumarthi, R. K., & Kilduff, T. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.014
Steiner, R. C., & Picciotto, M. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.025
10.2 Neuropharmacological Profiles of Antipsychotic Drugs
Roth, B. L., & Rogan, S. C. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0037
Review Recent advances in the genetics of schizophrenia
Waterworth, D. M., Bassett, A. S., & Brzustowicz, L. M. (2002)
Mackowick, M. K. (2014) · TSpace (University of Toronto)
Azimi, M. (2017) · YorkSpace (York University)
Haustein, K.-O. (2003) · Springer eBooks · doi:10.1007/978-3-662-05256-3_7
Substance dependence and abuse
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.024
Oro-pharyngeal mucosal microbiome alternations causing immune system dysregulation in schizophrenia
Krishnan, D., Ghosh, P., Lakshman, N., Justin, A., & Ramasamy, S. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.003 · Cited by 1
Steinhafel, N. W. (2006) · ScholarsArchive (Brigham Young University)
An Analysis of Nicotine Exacerbation of Reductions in PPI in a Rodent Model of Schizophrenia.
Maple, A. M. (2007) · Digital Commons - East Tennessee State University (East Tennessee State University)
BindingDB Entry 50038292: Allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
BindingDB (2012) · UC San Diego · doi:10.7270/q2ws8v3b
Neuronal nicotinic receptors as targets for enhancing cognition in schizophrenia
Rushforth, S. L. (2013)
Perna, M. K. (2012) · Digital Commons - East Tennessee State University (East Tennessee State University)
Metadata
- Authors
- Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R., & Freedman, R.
- Affiliations
- Veterans Health Administration (US)
- Auburn University (US)
- Corresponding author
- Leonard, Sherry
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 393
- Issue
- 1-3
- Pages
- 237-242
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2058494585
- Cited by
- 177
- References
- 70
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 8 · 2012: 12
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- schizophrenia, smoking, neuronal nicotinic acetylcholine receptors, gene expression, gene duplication, receptor gating, postmortem brain, alpha-bungarotoxin, methyllycaconitine, genetic linkage
- MeSH terms
- Animals, Brain, Chromosome Mapping, Chromosomes, Human, Pair 15, Cloning, Molecular, Disease Models, Animal, Humans, Leukocytes, Mononuclear, Nicotine, Receptors, Nicotinic, Schizophrenia, Smoking, Gene Expression, Mice, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review